Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

A systems approach to HIV-1 vaccines

Nature Biotechnology volume 34, pages 44–46 (2016)Cite this article

Subjects

Understanding the full breadth of immune responses that protect against HIV-1 may speed vaccine development.

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: An integrated serological profiling approach reported by Chung et al.1 for identification of unique humoral Fc-related vaccine signatures (left) compared to other approaches (right).

Katie Vicari/Nature Publishing Group

References

  1. Chung, A.W. et al. Cell 163, 988–998 (2015).

    Article  CAS  Google Scholar 

  2. Shibata, R. et al. Nat. Med. 5, 204–210 (1999).

    Article  CAS  Google Scholar 

  3. Caskey, M. et al. Nature 522, 487–491 (2015).

    Article  CAS  Google Scholar 

  4. Xiao, X. et al. Biochem. Biophys. Res. Commun. 390, 404–409 (2009).

    Article  CAS  Google Scholar 

  5. Dimitrov, D.S. MAbs 2, 347–356 (2010).

    Article  Google Scholar 

  6. Haynes, B.F., Kelsoe, G., Harrison, S.C. & Kepler, T.B. Nat. Biotechnol. 30, 423–433 (2012).

    Article  CAS  Google Scholar 

  7. Rerks-Ngarm, S. et al.; MOPH-TAVEG Investigators. N. Engl. J. Med. 361, 2209–2220 (2009).

    Article  CAS  Google Scholar 

  8. Haynes, B.F. et al. N. Engl. J. Med. 366, 1275–1286 (2012).

    Article  CAS  Google Scholar 

  9. Yates, N.L. et al. Sci. Transl. Med. 6, 228ra39 (2014).

    Article  Google Scholar 

  10. Chung, A.W.E. et al. Sci. Transl. Med. 6, 228ra38 (2014).

    Article  Google Scholar 

  11. Corey, L. et al. Sci. Transl. Med. 7, 310rv7 (2015).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Tianlei Ying is at the Key Laboratory of Medical Molecular Virology, Ministries of Education and Health, School of Basic Medical Sciences, Fudan University, Shanghai, China.,

    Tianlei Ying

  2. Ponraj Prabakaran is at the Intrexon Corporation, Germantown, USA.,

    Ponraj Prabakaran

  3. Dimiter Dimitrov is at the Center for Cancer Research, National Cancer Institute, National Institutes of Health, USA.,

    Dimiter S Dimitrov

Authors
  1. Tianlei Ying
    View author publications

    Search author on:PubMed Google Scholar

  2. Ponraj Prabakaran
    View author publications

    Search author on:PubMed Google Scholar

  3. Dimiter S Dimitrov
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Dimiter S Dimitrov.

Ethics declarations

Competing interests

Ponraj Prabakaran is a full-time employee of Intrexon Corporation.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ying, T., Prabakaran, P. & Dimitrov, D. A systems approach to HIV-1 vaccines. Nat Biotechnol 34, 44–46 (2016). https://doi.org/10.1038/nbt.3456

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/nbt.3456

This article is cited by

Search

Advanced search

Quick links

Nature Briefing Microbiology

Sign up for the Nature Briefing: Microbiology newsletter — what matters in microbiology research, free to your inbox weekly.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing: Microbiology